Sanofi and GlaxoSmithKline’s next generation Covid-19 vaccine could be used as a booster, after new data suggested that it elicits a strong immune response against the Omicron variant.
赛诺菲(Sanofi)和葛兰素史克(GlaxoSmithKline)的下一代新冠疫苗可以用作加强针，此前新的数据表明，该疫苗对奥密克戎变体引发了强烈的免疫反应。
您已阅读8%（265字），剩余92%（3193字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。